Maxim Group
http://www.maximgrp.com/Maxim Group is a financial services firm that provides investment banking, asset management, research, and sales & trading to a diverse range of corporate clients, institutional investors and high net worth individuals.
The firm’s research division uses fundamental research and a “bottom up” approach to making investment recommendations. Maxim’s research analysts focus on under-covered, small- to mid-cap names in a variety of sectors including healthcare, technology, retail and others.
View Older Stories View More Recent Stories
-
Contango ORE completes $50 million public offering of stock and warrants
-
CONTANGO ORE CLOSES $50 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
-
NioCorp prices $60 million public offering at $6.15 per share
-
NioCorp Announces Pricing of $60.0 Million Public Offering of Common Shares
-
GenSight Biologics Announces Successful Fundraising Amounting to Nearly EUR 3.7 Million
-
NioCorp begins proposed public offering of common shares
-
NioCorp Announces Commencement of Proposed Public Offering of Common Shares
-
CTGO prices $50 million stock offering at $20 per share
-
CONTANGO ORE ANNOUNCES $50 MILLION UNDERWRITTEN PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS
-
Scienture Holdings enters $9.2 million at-the-market equity offering agreement
-
Maxim Group Starts Xcel Brands (XELB) at Buy, PT $3
-
Caledonia Mining Corporation (CMCL) PT Raised to $48 at Maxim Group
-
NioCorp closes $50 million registered direct offering
-
NioCorp Announces Closing of $50.0 Million Registered Direct Offering of Common Shares
-
Maxim Group Downgrades Data Storage Corporation (DTST) to Hold
-
Co-Diagnostics closes $3.8 million stock offering
-
Co-Diagnostics, Inc. Announces Closing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
Helius raises over $500 million to build Solana treasury company
-
Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Closes Over $500 Million Private Placement to Launch SOL Treasury Company
-
Co-Diagnostics raises $3.8 million in registered direct offering
-
Co-Diagnostics, Inc. Announces Pricing of $3.8 Million Registered Direct Offering of Common Stock Priced At-The-Market Under Nasdaq Rules
-
NioCorp prices $50 million share offering at $5 per share
-
NioCorp Announces Pricing of $50.0 Million Registered Direct Offering of Common Shares
-
AmpliTech Group integrates AI/ML into 5G and WiFi radio products
-
AmpliTech Group Advances AI/ML Integration to Enhance ORAN 5G, Private Networks, and WiFi 6/7 Solutions
-
Robin Energy completes $8.6 million public offering
-
Robin Energy Announces Closing of $8.6 Million Public Offering of Common Stock
-
Helius raises over $500 million to launch Solana treasury strategy
-
Helius (NASDAQ:HSDT), in Partnership with Pantera Capital and Summer Capital Announces Over $500 Million in Funding to Launch SOL Treasury Company
-
Maxim Group Upgrades CNS Pharmasceuticals Inc. (CNSP) to Buy
-
Lucid Diagnostics closes $28.8 million stock offering
-
Lucid Diagnostics Announces Closing of Public Offering of Common Stock
-
SELLAS Life Sciences receives $23.6 million from warrant exercise
-
Robin Energy prices $7.5 million public offering at $1.30 per share
-
SELLAS Life Sciences Group Announces Exercise of Existing Warrants Held by a Current Institutional Investor for $23.6 Million in Gross Proceeds
-
Robin Energy Announces Pricing of $7.5 Million Public Offering of Common Stock
-
Maxim Group Starts Gold Royalty Corp. (GROY) at Buy
-
Robin Energy announces public offering of common stock
-
Robin Energy Announces Proposed Public Offering of Common Stock
-
Citius Oncology closes $9 million equity offering
-
Citius Oncology Announces Closing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
-
Neuphoria Therapeutics Inc. (NEUP) PT Raised to $35 at Maxim Group
-
Ondas Holdings Inc. Announces Closing of $230 Million Offering Including Full Exercise of Over-allotment Option
-
Lucid Diagnostics prices 25 million share offering at $1.00 per share
-
Lucid Diagnostics Announces Pricing of Public Offering of Common Stock
-
Lucid Diagnostics announces proposed public stock offering
-
Lucid Diagnostics announces proposed public stock offering
-
Lucid Diagnostics Announces Proposed Public Offering of Common Stock
-
Citius Oncology prices $9 million offering at $1.75 per share
-
Citius Oncology Announces Pricing of $9.0 Million Registered Direct Offering and Concurrent Private Placement
